faculty

Projects

Home / Projects / Surveillance of multidrug-resistant, extensively drug-resistant and pan drug-resistant organisms for the healthcare facilities using automated antimicrobial susceptibility system—A large scale national multicentric study

Surveillance of multidrug-resistant, extensively drug-resistant and pan drug-resistant organisms for the healthcare facilities using automated antimicrobial susceptibility system—A large scale national multicentric study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - Ongoing

Project Lead

Dr. Savitha Nagaraj, Dr. Supriya B G, Dr. Priyadarshini

Authors

Dr. Savitha Nagaraj, Dr. Supriya B G, Dr. Priyadarshini

Project Status

ongoing

Project Type

(V-AMR Study)